Evidence map›Paper›PMID 32759582›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Recurrent HyperCKemia with Immunological Involvement of the Endomysial Capillaries in Neuromyelitis Optica.

Ryuta Kinno, Yuyuko Osakabe, Seiya Takahashi, Shinji Kurokawa, Yoshiyuki Owan, Jun Shimizu, Kenjiro Ono, Yasuhiko Baba

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ryuta KinnoDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Yuyuko OsakabeDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Seiya TakahashiDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Shinji KurokawaDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Yoshiyuki OwanDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Jun ShimizuDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Kenjiro OnoDivision of Neurology, Department of Medicine, Showa University School of Medicine, Japan.
Yasuhiko BabaDepartment of Neurology, Showa University Fujigaoka Hospital, Japan.
Showa University Fujigaoka Hospital · JPShowa University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 55-year-old woman with neuromyelitis optica (NMO) had recurrent myalgias with hyperCKemia. A muscle biopsy suggested nonspecific myopathic changes. Regarding immunohistochemistry, the expression of both major histocompatibility complex class I and myxovirus resistance protein A was observed in the endomysial capillaries, suggesting immunological involvement of these capillaries, whereas both C5b9 (membrane attack complex) and aquaporin 4 immunofluorescence stainings were normal. The present findings led us to conclude that one possible mechanism for hyperCKemia in NMO underlying the immunological involvement of the endomysial capillaries was an as-yet-unidentified factor that triggered damage to the integrity of the sarcolemma and thereby cause CK leakage into the serum.

Indexed as

Aquaporin 4AutoantibodiesCreatine KinaseFemaleHumansMiddle AgedMuscle, SkeletalNeuromyelitis OpticaAquaporin 4AutoantibodiesCreatine Kinaseendomysial capillarieshyperCKemiamajor histocompatibility complex class Imyxovirus resistance protein Aneuromyelitis optica

Identifiers

PMID32759582
PMCPMC7759704
OpenAlexW3047023180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.